Pediatric eye disease investigator group amblyopia treatment review

Insights

Most eye care professionals continue traditional amblyopia treatment methods, like patching, despite recent Pediatric Eye Disease Investigator Group (PEDIG) studies. Their practices show minimal changes in response to new amblyopia treatment research.

Area of Science:

  • Ophthalmology
  • Pediatric Eye Care
  • Clinical Research

Background:

  • The Pediatric Eye Disease Investigator Group (PEDIG) conducts vital clinical research on pediatric eye conditions.
  • PEDIG's Amblyopia Treatment Studies (ATS) have investigated various treatment regimens and their long-term outcomes.
  • Four ATS studies are published, with four more pending release.

Purpose of the Study:

  • To assess how ophthalmologists and orthoptists in British Columbia are adapting their amblyopia treatment strategies.
  • To understand the influence of recent PEDIG studies on clinical practice regarding amblyopia management.

Main Methods:

  • A survey was administered to ophthalmologists and orthoptists at a seminar in British Columbia.
  • Participants were questioned about their current amblyopia treatment protocols in light of PEDIG findings.

Main Results:

  • Ninety percent of respondents use patching as the primary treatment for moderate amblyopia.
  • Over 50% use patching for 4+ hours daily, with 83% incorporating near exercises.
  • Two-thirds use patching for 6+ hours daily for severe amblyopia; atropine is used daily by those who employ it.
  • Most believe amblyopia is treatable up to age 12-14 years.

Conclusions:

  • The majority of surveyed ophthalmologists and orthoptists have not significantly altered their amblyopia treatment approaches.
  • Clinical practices appear slow to integrate findings from recent PEDIG amblyopia research.
Abstract